TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples